|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.045 NOK | -0.48% |
|
-7.52% | -43.05% |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | -40.5 | -24.84 | -21.19 | -33.89 | -21.23 | |||||
Return on Total Capital | -49.11 | -29.46 | -25.28 | -41.79 | -26.27 | |||||
Return On Equity % | -87.76 | -51.86 | -40.25 | -69.06 | -42.43 | |||||
Return on Common Equity | -87.76 | -51.86 | -40.25 | -69.06 | -42.43 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 14.53 | 17.68 | 30.55 | 21.46 | 54.71 | |||||
SG&A Margin | 103.44 | 76.12 | 69.27 | 99.6 | 43.07 | |||||
EBITDA Margin % | -150.35 | -104.25 | -88.48 | -175.33 | -59.77 | |||||
EBITA Margin % | -159.35 | -111.6 | -96.66 | -186.65 | -63.3 | |||||
EBIT Margin % | -170.66 | -114.77 | -99.54 | -189.85 | -64.36 | |||||
Income From Continuing Operations Margin % | -176.16 | -118.24 | -95.94 | -191.18 | -63.2 | |||||
Net Income Margin % | -176.16 | -118.24 | -95.94 | -191.18 | -63.2 | |||||
Net Avail. For Common Margin % | -176.16 | -118.24 | -95.94 | -191.18 | -63.2 | |||||
Normalized Net Income Margin | -106.22 | -71.91 | -60.04 | -116.99 | -39.33 | |||||
Levered Free Cash Flow Margin | -84.54 | -36.62 | -35.74 | -99.32 | -73.54 | |||||
Unlevered Free Cash Flow Margin | -83.66 | -36.2 | -35.57 | -98.76 | -73.41 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.38 | 0.35 | 0.34 | 0.29 | 0.53 | |||||
Fixed Assets Turnover | 2.39 | 3.02 | 3.35 | 3.6 | 10.35 | |||||
Receivables Turnover (Average Receivables) | 14.38 | 5.9 | 5.01 | 3.63 | 2.07 | |||||
Inventory Turnover (Average Inventory) | 2.07 | 2.05 | 1.6 | 1.17 | 1.59 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 3.95 | 5.56 | 4.35 | 4.54 | 4.62 | |||||
Quick Ratio | 3.04 | 4.71 | 3.33 | 3.49 | 3.95 | |||||
Operating Cash Flow to Current Liabilities | -2.94 | -1.88 | -1.32 | -2.33 | -1.97 | |||||
Days Sales Outstanding (Average Receivables) | 25.45 | 61.84 | 72.9 | 100.48 | 176.56 | |||||
Days Outstanding Inventory (Average Inventory) | 176.7 | 177.83 | 228.1 | 311.29 | 230.32 | |||||
Average Days Payable Outstanding | 92.54 | 83.36 | 70.89 | 92.34 | 114.66 | |||||
Cash Conversion Cycle (Average Days) | 109.6 | 156.31 | 230.12 | 319.43 | 292.22 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 11.53 | 3.35 | 3.09 | 2.06 | 3.44 | |||||
Total Debt / Total Capital | 10.34 | 3.24 | 3 | 2.01 | 3.32 | |||||
LT Debt/Equity | 6.97 | 1.41 | 1.27 | 0.21 | 1.89 | |||||
Long-Term Debt / Total Capital | 6.25 | 1.37 | 1.23 | 0.2 | 1.83 | |||||
Total Liabilities / Total Assets | 26.08 | 16.95 | 21.21 | 20.65 | 22 | |||||
EBIT / Interest Expense | -121.6 | -168.36 | -366.95 | -215.44 | -326.72 | |||||
EBITDA / Interest Expense | -102.76 | -147.92 | -311.76 | -192.11 | -288.47 | |||||
(EBITDA - Capex) / Interest Expense | -102.87 | -148.51 | -312.3 | -192.15 | -292.7 | |||||
Total Debt / EBITDA | -0.13 | -0.09 | -0.07 | -0.03 | -0.1 | |||||
Net Debt / EBITDA | 0.68 | 1.94 | 1.65 | 1.14 | 1.46 | |||||
Total Debt / (EBITDA - Capex) | -0.13 | -0.09 | -0.07 | -0.03 | -0.1 | |||||
Net Debt / (EBITDA - Capex) | 0.68 | 1.93 | 1.64 | 1.14 | 1.43 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -31.56 | -12.17 | -4.85 | -28.8 | 108.17 | |||||
Gross Profit, 1 Yr. Growth % | -59.17 | 6.83 | 46.44 | -49.98 | 430.67 | |||||
EBITDA, 1 Yr. Growth % | -43 | -39.1 | -19.24 | 41.09 | -29.03 | |||||
EBITA, 1 Yr. Growth % | -41.57 | -38.49 | -17.6 | 37.49 | -29.4 | |||||
EBIT, 1 Yr. Growth % | -40.08 | -40.93 | -17.48 | 35.8 | -29.43 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -38.84 | -41.04 | -22.8 | 41.87 | -31.18 | |||||
Net Income, 1 Yr. Growth % | -38.84 | -41.04 | -22.8 | 41.87 | -31.18 | |||||
Normalized Net Income, 1 Yr. Growth % | -40.23 | -40.54 | -20.55 | 38.73 | -30.02 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -52.65 | -41.04 | -24.94 | 36.86 | -38.93 | |||||
Accounts Receivable, 1 Yr. Growth % | 30.8 | 170.55 | -49.17 | 96.5 | 361.3 | |||||
Inventory, 1 Yr. Growth % | -16.32 | -12.6 | 20.79 | 0.83 | -23.58 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -44.9 | -4.36 | -25.19 | -45.43 | 5.28 | |||||
Total Assets, 1 Yr. Growth % | -23.96 | 22.95 | -24.62 | -2.42 | 28.17 | |||||
Tangible Book Value, 1 Yr. Growth % | -25.31 | 42 | -28.32 | -0.64 | 27.16 | |||||
Common Equity, 1 Yr. Growth % | -27.9 | 38.14 | -28.49 | -1.72 | 25.97 | |||||
Cash From Operations, 1 Yr. Growth % | -38.83 | -40.67 | -32.09 | 70.97 | 8.92 | |||||
Capital Expenditures, 1 Yr. Growth % | -92.66 | 131.82 | -65.69 | -81.43 | 4.49K | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -29.28 | -61.95 | -7.15 | 97.85 | 54.14 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -29.57 | -62 | -6.5 | 97.69 | 54.74 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -26.98 | -22.47 | -8.58 | -17.69 | 21.74 | |||||
Gross Profit, 2 Yr. CAGR % | -47.76 | -33.95 | 32.52 | -14.41 | 62.93 | |||||
EBITDA, 2 Yr. CAGR % | -26.51 | -41.08 | -29.87 | 6.74 | 0.06 | |||||
EBITA, 2 Yr. CAGR % | -25.22 | -40.05 | -28.8 | 6.44 | -1.48 | |||||
EBIT, 2 Yr. CAGR % | -24.03 | -40.51 | -30.18 | 5.86 | -2.1 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -23.27 | -39.95 | -32.53 | 4.66 | -1.19 | |||||
Net Income, 2 Yr. CAGR % | -23.27 | -39.95 | -32.53 | 4.66 | -1.19 | |||||
Normalized Net Income, 2 Yr. CAGR % | -24.29 | -40.39 | -31.27 | 4.98 | -1.47 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -46.53 | -55.16 | -33.48 | 1.36 | -8.58 | |||||
Accounts Receivable, 2 Yr. CAGR % | -40.35 | 88.11 | 17.27 | -0.06 | 201.08 | |||||
Inventory, 2 Yr. CAGR % | -14 | -14.48 | 2.75 | 10.36 | -12.22 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | -20.38 | -27.41 | -15.27 | -36.1 | -24.2 | |||||
Total Assets, 2 Yr. CAGR % | -6.39 | -3.31 | -3.73 | -14.24 | 11.83 | |||||
Tangible Book Value, 2 Yr. CAGR % | -4.38 | 2.98 | 0.91 | -15.61 | 12.4 | |||||
Common Equity, 2 Yr. CAGR % | -9.74 | -0.2 | -0.61 | -16.17 | 11.27 | |||||
Cash From Operations, 2 Yr. CAGR % | -25.4 | -39.76 | -36.53 | 8.98 | 36.46 | |||||
Capital Expenditures, 2 Yr. CAGR % | -55.13 | -58.75 | -10.81 | -74.76 | 192.04 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -22.67 | -48.13 | -40.56 | 35.54 | 74.63 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -23.07 | -48.27 | -40.39 | 35.96 | 74.9 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | -16.19 | -22.35 | -16.99 | -15.89 | 12.14 | |||||
Gross Profit, 3 Yr. CAGR % | 12.78 | -33.69 | -10.49 | -4.22 | 57.24 | |||||
EBITDA, 3 Yr. CAGR % | -18.96 | -30.97 | -34.55 | -11.47 | -6.84 | |||||
EBITA, 3 Yr. CAGR % | -18.04 | -29.94 | -33.34 | -11.34 | -7.17 | |||||
EBIT, 3 Yr. CAGR % | -16.27 | -30.15 | -33.65 | -12.85 | -7.52 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -17.43 | -29.72 | -34.71 | -13.57 | -8.99 | |||||
Net Income, 3 Yr. CAGR % | -17.43 | -29.72 | -34.71 | -13.57 | -8.99 | |||||
Normalized Net Income, 3 Yr. CAGR % | -16.42 | -30.15 | -34.4 | -13.14 | -8.29 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -47.77 | -50.49 | -46.76 | -15.39 | -14.39 | |||||
Accounts Receivable, 3 Yr. CAGR % | -34.99 | -1.26 | 21.61 | 39.28 | 66.4 | |||||
Inventory, 3 Yr. CAGR % | -8.13 | -13.54 | -4.05 | 2.1 | -2.36 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | -17.01 | -15.36 | -26.59 | -26.83 | -24.53 | |||||
Total Assets, 3 Yr. CAGR % | -12.37 | 2.52 | -11.01 | -3.3 | -1.95 | |||||
Tangible Book Value, 3 Yr. CAGR % | -13.89 | 9.09 | -8.72 | 0.39 | -3.25 | |||||
Common Equity, 3 Yr. CAGR % | -16.2 | 4.02 | -10.7 | -0.98 | -3.98 | |||||
Cash From Operations, 3 Yr. CAGR % | -18.34 | -30.88 | -37.31 | -11.01 | 8.96 | |||||
Capital Expenditures, 3 Yr. CAGR % | -85.57 | -22.43 | -61.21 | -47.14 | 43.04 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -24.9 | -38.95 | -37.02 | -11.25 | 41.47 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -25.16 | -39.19 | -36.98 | -11.11 | 41.95 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 66.1 | -11.23 | -13.23 | -20.52 | -3.25 | |||||
Gross Profit, 5 Yr. CAGR % | 12.94 | -37.71 | 20.3 | -24.85 | 13.74 | |||||
EBITDA, 5 Yr. CAGR % | -6.25 | -22.34 | -23.52 | -17.82 | -22.44 | |||||
EBITA, 5 Yr. CAGR % | -5.39 | -21.55 | -22.53 | -17.18 | -22.07 | |||||
EBIT, 5 Yr. CAGR % | -4.14 | -21.15 | -22.14 | -17.51 | -22.48 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -3.48 | -20.8 | -23.84 | -17.59 | -22.94 | |||||
Net Income, 5 Yr. CAGR % | -3.48 | -20.8 | -23.84 | -17.59 | -22.94 | |||||
Normalized Net Income, 5 Yr. CAGR % | -3.79 | -21.23 | -22.71 | -17.78 | -22.81 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -31.42 | -44.95 | -46.12 | -34.06 | -33.91 | |||||
Accounts Receivable, 5 Yr. CAGR % | 22.1 | -1.65 | -17.69 | -0.78 | 74.77 | |||||
Inventory, 5 Yr. CAGR % | -0.38 | -4.1 | -3.92 | -4.67 | -7.4 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | -1.69 | 0.25 | -16.32 | -24.31 | -25.64 | |||||
Total Assets, 5 Yr. CAGR % | -7.37 | -4.31 | -9.01 | -4.55 | -2.49 | |||||
Tangible Book Value, 5 Yr. CAGR % | -11.15 | -3.77 | -8.25 | -1.55 | -0.79 | |||||
Common Equity, 5 Yr. CAGR % | -10.86 | -5.4 | -10.28 | -4.58 | -2.49 | |||||
Cash From Operations, 5 Yr. CAGR % | -6.02 | -24.91 | -26.17 | -17.07 | -14.04 | |||||
Capital Expenditures, 5 Yr. CAGR % | -65.6 | -24.44 | -70.09 | -50.49 | -13.02 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -8.37 | -33.24 | -31.61 | -16.01 | -5.29 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -8.55 | -33.39 | -31.67 | -16.1 | -5.21 |
- Stock Market
- Equities
- NEXT Stock
- Financials NEXT Biometrics Group ASA
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















